135 MEF25 as parameter to evaluate effects of mannitol inhalation  by Leichsenring, M. & Meissner, P.
Posters 8. Pulmonology S81
133 Slow and fast lung compartments in cystic ﬁbrosis measured by
nitrogen multiple-breath washout (N2 MBW)
B. Houltz1, M. Gilljam2, A. Lindblad3, P.D. Robinson4, P. Gustafsson5.
1Sahlgrenska University Hospital/East, Clinical Physiology, Gothenburg, Sweden;
2Sahlgrenska University Hospital, Dept of Pulmonology and Allergology,
Gothenburg, Sweden; 3Queen Silvia Childrens Hospital, Dept of Pediatrics,
Gothenburg, Sweden; 4The Children’s Hospital at Westmead, Dept of Respiratory
Medicine, Sydney, Australia; 5Skaraborg Hospital, Dept of Pediatrics, Skovde,
Sweden
Objectives: To demonstrate that the volumes of under-ventilated lung regions and
their speciﬁc ventilation can be measured from routine N2 MBW tests in CF.
Methods: Triplets of N2 MBW in 37 CF subjects aged 11−45 years and 74 age and
sex matched controls. The fast and slow ventilating lung compartments and their
speciﬁc ventilation were determined from semi-log plots of expired N2 volume per
breath vs breath number.
Results: Two-compartment lung emptying was not seen in healthy controls but
in all CF subjects (FEV1 mean (SD) 84.8 (19.9) %predicted; abnormal Lung
Clearance Index (LCI) in 36/37, range 7.28–18.89). In CF, the slowly ventilated
lung compartment ranged from 34−67% of full FRC, with speciﬁc ventilation
(regional alveolar tidal volume/regional lung volume) 1.8–13.1%. LCI increased as
speciﬁc ventilation of the slowly ventilated lung compartment decreased (r2=0.70,
p< 0.001). Over-ventilation of the fast lung compartment occurred in early but not
late disease.
Conclusion: The magnitude and function of under- and over-ventilated lung
volumes can be easily derived from routine N2 MBW in CF. Reported values
agree with previous modelling-derived estimates of impaired ventilation. The new
compartment analysis extends our understanding of CF lung pathophysiology.
134 Nutritional status, lung function and LCI among children with CF
E. Hatziagorou1, V. Katseni2, A. Kampouras1, V. Avramidou1, D. Lamboudis2,
T. Karagiozoglou-Lampoudi2, J.N. Tsanakas1. 1Aristotle University of Thessaloniki,
Hippokration Hospital, 3rd Paediatric Dept, Thessaloniki, Greece; 2Technological
Education Institute, Dept of Nutrition/Dietetics, School of Food Technology and
Nutrition, Thessaloniki, Greece
Background: Nutritional status in patients with cystic ﬁbrosis is associated disease
outcome. Lung function and Lung Clearance Index (LCI) are both good predictors
of disease severity.
Aim: To evaluate the association between nutritional status and lung function and
LCI among children and adolescents with CF.
Methods: Nutritional status and pulmonary function of 77 patients with CF
(53.2% males, mean age 10.73 years), were evaluated. Anthropometry was ex-
pressed as z-scores for age and sex using WHO Anthro software and classiﬁed
following the WHO criteria, and Frisancho references for Mid-Upper Arm Circum-
ference percentile (MUACp) and Triceps Skinfold Thickness percentile (TSTp).
BMIpercentile (BMIp) was also calculated. Phase angle (PhA) and body cell
mass (BCM) were assessed by BIA. Disease severity was assessed by FEV1
(ATS/ERS guidelines), LCI (measured by multiple breath washout test, (EXHA-
LYZER D, Ecomedics).
Results: The mean value for Weight/Height z score was −0.04 (±1.65), Height/age
z was −0.37 (±1.19), Weight/age z was −0.22 (±1.39), BMI/age z was 0.07 (±1.32),
MUACz was −0.12 (±1.29), TSFz was 0.06 (±1.03). The mean value of the BMIp
was 50.16. The mean PhA value was 4.94 (±0.91). Mean values for the respiratory
tests were FEV1: 90 (±25)% predicted and LCI: 9.36±2.99.
Statistically signiﬁcant correlation was found between FEV1% and BMIp, WAz,
BAz and PhA (p = 0.001, p = 0.009, p = 0.001, p = 0.001, respectively). LCI was
signiﬁcantly related only with BMIp, (p = 0.004).
Conclusions: All the nutritional status parameters seem to correlate signiﬁcantly
with FEV1 in CF patients. However, only BMI has a signiﬁcant correlation
with LCI.
135 MEF25 as parameter to evaluate effects of mannitol inhalation
M. Leichsenring1, P. Meissner1. 1Ulm University, Ulm, Germany
Objectives: In our centre various parameters (absence of side effects, improvement
of lung function, increased sputum mobilisation, subjective improvement) are used
to evaluate the effect of mannitol inhalation 6 (4−8) weeks after start of therapy. If
no positive effect is seen, mannitol inhalation is discontinued. However, the results
for various lung function parameters are not always congruent. We investigated
differences between FEV1 and MEF25 results.
Methods: After initiation dose assessment patients were treated with inhalative
mannitol 400mg twice daily. After 6 (4−8) weeks effects of therapy were evaluated
by medical history and whole body plethysmography. Complete data could be
collected from 18 patients. Results for lung function parameters before and after
introduction of therapy were compared by Wilcoxon matched-pairs signed ranking
test. p< 0.05 was chosen as level of signiﬁcance.
Results: In contrast to previous clinical studies with larger groups of patients we
did not see a signiﬁcant improvement of FEV1 after introduction of therapy (before
mean 60.5%, 95%CI 49.7–71.3%, median 56.4%; after mean 61.6%, 95%CI
49.9–73.2%, median 60.2%; p = 0.79, n.s.) in our patients. Only 5/18 showed an
improvement of FEV1 >10%. However, MEF25 improved signiﬁcantly (before
mean 18.9%, 95%CI 12.3–25.5%, median 15.3%; after mean 26.1%, 95%CI 16.9–
35.4%, median 22.8%; p< 0.005). 6/18 patients showed no improvement of both
FEV1 and MEF25.
Conclusion: MEF25 may serve as an additional, more sensitive parameter to
evaluate the effects of mannitol inhalation.
136 Nocturnal oximetry in children with cystic ﬁbrosis (CF)
E.L. Stockley1, N. Patel1, M. Rosenthal1, H.-L. Tan1. 1Royal Brompton &
Hareﬁeld NHS Foundation Trust, Paediatric Respiratory Medicine, London, United
Kingdom
Objectives: Intermittent nocturnal observations may miss oxygen desaturations
occurring during REM sleep. In our unit, nocturnal oximetry is performed on the
ﬁrst night of admission for all CF children. Night-time monitoring is discontinued if
oxygenation is normal and the patient is improving. We aimed to determine whether
daytime physiology is predictive of nocturnal hypoxaemia.
Methods: A retrospective comparison of nocturnal oximetry, daytime physiology
and HbA1c of all CF children admitted in the past year.
Results: 76 children with CF were admitted, 21/76 elective and 55/76 acute
admissions. Table 1 summarises the clinical characteristics and nocturnal oximetry
results. There was a weak positive correlation between Mean SpO2 and admission
FEV1 (p 0.0001, r
2=0.27) and admission FVC (p = 0.0003, r2=0.18). Nocturnal
oxygen was commenced in 4/76 children (5.2%) as their mean SpO2 <93%. All of
them had an FVC <60%. 3 of the children improved, 1 died.
Conclusion: Patients with an admission FVC of <60% warrant close monitoring
for nocturnal hypoxaemia. In those who are cardiovascularly stable, performing an
oximetry study on their ﬁrst night of admission may be less disruptive than routine
observations for the whole admission.
Table: Clinical characteristics and nocturnal oximetry results
Age (years) median [range] 12 [0.1–17.5]
Admission FEV1 (% predicted) mean [95%CI] 75 [70.67–79.4]
Admission FVC (% predicted) mean [95%CI] 84 [80–88.4]
Best FEV1 in past year (% predicted) mean [95%CI] 89.2 [85.4−93]
Best FVC in past year (% predicted) mean [95%CI] 97.7 [94.3–101]
Mean SpO2 (%) median [range] 97 [91.4–99.7]
Desaturations 4%/hour median [range] 1.1 [0–10.05]
Percentage time O2 saturations <90% median [range] 0.02 [0–10.9]
HbA1c (%) median [range] 5.7 [4.2−7.1]
